Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Original Research 


Serum melanin and alpha-melanocyte stimulating hormone (α-MSH) levels in Pakistani individuals affected with oculocutaneous albinism

Muhammad Shakil, Kaukab Sultana, Rana Naveed Iqbal, Muhammad Ikram Ullah, Shabbir Hussain, Saqib Mahmood.

Abstract
Objective: To determine the serum levels of melanin, α-MSH, and to find their association and correlation in patients with Oculocutaneous albinism (OCA).
Methodology: This study included 80 subjects; 40 OCA patients and 40 healthy controls. ELISA was performed to determine the serum concentrations of melanin and α-MSH.
Results: Serum melanin level of 6.0 ng/dL was significantly reduced and serum levels of α-MSH of 9.8 ng/dL was significantly higher (p<0.05) in patients as compared to healthy controls who had 14 and 3.48, respectively.
Conclusion: serum melanin levels were found low with a compensatory rise in α-MSH levels in OCA patients as compared to controls.

Key words: Oculocutaneous albinism (OCA), melanin, alpha-melanocyte stimulating hormone (α-MSH), Pakistan.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Muhammad Shakil
Articles by Kaukab Sultana
Articles by Rana Naveed Iqbal
Articles by Muhammad Ikram Ullah
Articles by Shabbir Hussain
Articles by Saqib Mahmood
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Shakil M, Sultana K, Iqbal RN, Ullah MI, Hussain S, Mahmood S. Serum melanin and alpha-melanocyte stimulating hormone (α-MSH) levels in Pakistani individuals affected with oculocutaneous albinism. RMJ. 2022; 47(1): 30-33.


Web Style

Shakil M, Sultana K, Iqbal RN, Ullah MI, Hussain S, Mahmood S. Serum melanin and alpha-melanocyte stimulating hormone (α-MSH) levels in Pakistani individuals affected with oculocutaneous albinism. https://www.rmj.org.pk/?mno=51959 [Access: April 05, 2022].


AMA (American Medical Association) Style

Shakil M, Sultana K, Iqbal RN, Ullah MI, Hussain S, Mahmood S. Serum melanin and alpha-melanocyte stimulating hormone (α-MSH) levels in Pakistani individuals affected with oculocutaneous albinism. RMJ. 2022; 47(1): 30-33.



Vancouver/ICMJE Style

Shakil M, Sultana K, Iqbal RN, Ullah MI, Hussain S, Mahmood S. Serum melanin and alpha-melanocyte stimulating hormone (α-MSH) levels in Pakistani individuals affected with oculocutaneous albinism. RMJ. (2022), [cited April 05, 2022]; 47(1): 30-33.



Harvard Style

Shakil, M., Sultana, . K., Iqbal, . R. N., Ullah, . M. I., Hussain, . S. & Mahmood, . S. (2022) Serum melanin and alpha-melanocyte stimulating hormone (α-MSH) levels in Pakistani individuals affected with oculocutaneous albinism. RMJ, 47 (1), 30-33.



Turabian Style

Shakil, Muhammad, Kaukab Sultana, Rana Naveed Iqbal, Muhammad Ikram Ullah, Shabbir Hussain, and Saqib Mahmood. 2022. Serum melanin and alpha-melanocyte stimulating hormone (α-MSH) levels in Pakistani individuals affected with oculocutaneous albinism. Rawal Medical Journal, 47 (1), 30-33.



Chicago Style

Shakil, Muhammad, Kaukab Sultana, Rana Naveed Iqbal, Muhammad Ikram Ullah, Shabbir Hussain, and Saqib Mahmood. "Serum melanin and alpha-melanocyte stimulating hormone (α-MSH) levels in Pakistani individuals affected with oculocutaneous albinism." Rawal Medical Journal 47 (2022), 30-33.



MLA (The Modern Language Association) Style

Shakil, Muhammad, Kaukab Sultana, Rana Naveed Iqbal, Muhammad Ikram Ullah, Shabbir Hussain, and Saqib Mahmood. "Serum melanin and alpha-melanocyte stimulating hormone (α-MSH) levels in Pakistani individuals affected with oculocutaneous albinism." Rawal Medical Journal 47.1 (2022), 30-33. Print.



APA (American Psychological Association) Style

Shakil, M., Sultana, . K., Iqbal, . R. N., Ullah, . M. I., Hussain, . S. & Mahmood, . S. (2022) Serum melanin and alpha-melanocyte stimulating hormone (α-MSH) levels in Pakistani individuals affected with oculocutaneous albinism. Rawal Medical Journal, 47 (1), 30-33.








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


Indexed in WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED,  Scopus, Web of Science and Tehqeeqat

                     Approved by the Higher Education Commission of Pakistan 


ABOUT JOURNAL
POLICIES
STATEMENTS

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.

The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.